KLEA HOLDING(EPA:ALKLH) stock Fundamental Analysis

Fundamental Rating

We assign a fundamental rating of 3 out of 10 to ALKLH. ALKLH was compared to 55 industry peers in the Health Care Equipment & Supplies industry. ALKLH has a bad profitability rating. Also its financial health evaluation is rather negative. ALKLH is quite expensive at the moment. It does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

ALKLH had negative earnings in the past year.

ALKLH had a positive operating cash flow in the past year.

In the past 5 years ALKLH reported 4 times negative net income.

ALKLH had negative operating cash flow in 4 of the past 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of 4.52%, ALKLH is in the better half of the industry, outperforming 70.91% of the companies in the same industry.

The Return On Equity of ALKLH (6.26%) is comparable to the rest of the industry.

ALKLH has a Return On Invested Capital of 2.49%. This is comparable to the rest of the industry: ALKLH outperforms 49.09% of its industry peers.

		Industry Rank	Sector Rank
ROA	4.52%
ROE	6.26%
ROIC	2.49%

ROA(3y)-7.42%

ROA(5y)-54.54%

ROE(3y)-16.55%

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

Looking at the Profit Margin, with a value of 10.78%, ALKLH is in the better half of the industry, outperforming 76.36% of the companies in the same industry.

ALKLH has a Operating Margin of 6.26%. This is comparable to the rest of the industry: ALKLH outperforms 54.55% of its industry peers.

With an excellent Gross Margin value of 94.89%, ALKLH belongs to the best of the industry, outperforming 94.55% of the companies in the same industry.

In the last couple of years the Gross Margin of ALKLH has grown nicely.

		Industry Rank	Sector Rank
OM	6.26%
PM (TTM)	10.78%
GM	94.89%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y115.58%

GM growth 5Y16.29%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ALKLH is destroying value.

ALKLH has about the same amout of shares outstanding than it did 1 year ago.

The number of shares outstanding for ALKLH has been increased compared to 5 years ago.

The debt/assets ratio for ALKLH is higher compared to a year ago.

2.2 Solvency

An Altman-Z score of 3.67 indicates that ALKLH is not in any danger for bankruptcy at the moment.

The Altman-Z score of ALKLH (3.67) is better than 78.18% of its industry peers.

The Debt to FCF ratio of ALKLH is 19.51, which is on the high side as it means it would take ALKLH, 19.51 years of fcf income to pay off all of its debts.

Looking at the Debt to FCF ratio, with a value of 19.51, ALKLH is in line with its industry, outperforming 50.91% of the companies in the same industry.

ALKLH has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.

Looking at the Debt to Equity ratio, with a value of 0.01, ALKLH belongs to the top of the industry, outperforming 96.36% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	0.01
Debt/FCF	19.51
Altman-Z	3.67

ROIC/WACC0.33

WACC7.54%

2.3 Liquidity

A Current Ratio of 0.60 indicates that ALKLH may have some problems paying its short term obligations.

ALKLH has a Current ratio of 0.60. This is amonst the worse of the industry: ALKLH underperforms 83.64% of its industry peers.

ALKLH has a Quick Ratio of 0.60. This is a bad value and indicates that ALKLH is not financially healthy enough and could expect problems in meeting its short term obligations.

ALKLH has a worse Quick ratio (0.60) than 80.00% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	0.6
Quick Ratio	0.6

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 101.68% over the past year.

The Revenue has grown by 26.05% in the past year. This is a very strong growth!

Measured over the past years, ALKLH shows a quite strong growth in Revenue. The Revenue has been growing by 9.42% on average per year.

EPS 1Y (TTM)101.68%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%108.7%

Revenue 1Y (TTM)26.05%

Revenue growth 3Y-10.28%

Revenue growth 5Y9.42%

Sales Q2Q%23.13%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

The Revenue is expected to grow by 23.35% on average over the next years. This is a very strong growth

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year33.08%

Revenue Next 2Y27.7%

Revenue Next 3Y23.35%

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ALKLH indicates a somewhat cheap valuation: ALKLH is cheaper than 72.73% of the companies listed in the same industry.

The rest of the industry has a similar Price/Free Cash Flow ratio as ALKLH.

		Industry Rank	Sector Rank
P/FCF	219.97
EV/EBITDA	18

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for ALKLH!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

KLEA HOLDING

EPA:ALKLH (3/7/2025, 7:00:00 PM)

0.196

0 (-1.41%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Equipment & Supplies

Earnings (Last)07-29 2024-07-29

Earnings (Next)N/A N/A

Inst Owners1.26%

Inst Owner ChangeN/A

Ins OwnersN/A

Ins Owner ChangeN/A

Market Cap60.27M

Analysts86.67

Price Target0.51 (160.2%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)-28.57%

PT rev (3m)-28.57%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)-100%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)-5.46%

Revenue NY rev (3m)-5.46%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	3.97
P/FCF	219.97
P/OCF	24.65
P/B	2.31
P/tB	55.3
EV/EBITDA	18

EPS(TTM)0

EYN/A

EPS(NY)0

Fwd EYN/A

FCF(TTM)0

FCFY0.45%

OCF(TTM)0.01

OCFY4.06%

SpS0.05

BVpS0.09

TBVpS0

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	4.52%
ROE	6.26%
ROCE	3.39%
ROIC	2.49%
ROICexc	2.77%
ROICexgc	413.17%
OM	6.26%
PM (TTM)	10.78%
GM	94.89%
FCFM	1.8%

ROA(3y)-7.42%

ROA(5y)-54.54%

ROE(3y)-16.55%

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y115.58%

GM growth 5Y16.29%

F-Score7

Asset Turnover0.42

Health

		Industry Rank	Sector Rank
Debt/Equity	0.01
Debt/FCF	19.51
Debt/EBITDA	0.11
Cap/Depr	85.41%
Cap/Sales	14.3%
Interest Coverage	250
Cash Conversion	70.02%
Profit Quality	16.75%
Current Ratio	0.6
Quick Ratio	0.6
Altman-Z	3.67

F-Score7

WACC7.54%

ROIC/WACC0.33

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)19.98%

Cap/Sales(5y)12.36%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)101.68%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%108.7%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)26.05%

Revenue growth 3Y-10.28%

Revenue growth 5Y9.42%

Sales Q2Q%23.13%

Revenue Next Year33.08%

Revenue Next 2Y27.7%

Revenue Next 3Y23.35%

Revenue Next 5YN/A

EBIT growth 1Y131.41%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year3600%

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y116.25%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y623.37%

OCF growth 3YN/A

OCF growth 5YN/A

KLEA HOLDING (ALKLH.PA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens